BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16341812)

  • 21. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
    Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
    Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
    Llor X; Pons E; Xicola RM; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Roca A; Gassull MA;
    Clin Cancer Res; 2005 Oct; 11(20):7304-10. PubMed ID: 16243801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.
    Kuismanen SA; Moisio AL; Schweizer P; Truninger K; Salovaara R; Arola J; Butzow R; Jiricny J; Nyström-Lahti M; Peltomäki P
    Am J Pathol; 2002 Jun; 160(6):1953-8. PubMed ID: 12057899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1.
    Raevaara TE; Gerdes AM; Lönnqvist KE; Tybjaerg-Hansen A; Abdel-Rahman WM; Kariola R; Peltomäki P; Nyström-Lahti M
    Genes Chromosomes Cancer; 2004 Jul; 40(3):261-5. PubMed ID: 15139004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC)].
    Goldberg Y; Porat R; Sagi M; Eilat A; Kedar I; Shochat C; Mendelson S; Hamburger T; Nissan A; Hubert A; Shalev S; Bercovich D; Pikarski E; Lerer I; Abeliovich D; Pretetz T
    Harefuah; 2007 Jul; 146(7):510-4, 576, 575. PubMed ID: 17803162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
    Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
    Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive deficiency in DNA mismatch repair.
    Felton KE; Gilchrist DM; Andrew SE
    Clin Genet; 2007 Jun; 71(6):483-98. PubMed ID: 17539897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic features of International Collaborative Group-hereditary nonpolyposis colorectal cancer families and suspected hereditary nonpolyposis colorectal cancer families.
    Yuan Y; Ye J; Zheng S;
    Chin Med J (Engl); 2004 May; 117(5):748-52. PubMed ID: 15161546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HNPCC syndrome, microsatellite instability and NF1 gene alteration].
    Puisieux A
    Bull Cancer; 1999 Oct; 86(10):812-4. PubMed ID: 10572231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
    Boilesen AE; Bisgaard ML; Bernstein I
    Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification and genetic counseling of people with HNPCC (hereditary nonpolyposis colorectal cancer): old and new research goals].
    Müller H; Dobbie Z; Heinimann K
    Schweiz Med Wochenschr; 1999 Dec; 129(50):1978-85. PubMed ID: 10637951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.